| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/30/2002 | EP0536293B1 Increased starch content in plants |
| 01/30/2002 | EP0528857B1 New bacillus thuringiensis strain and its gene encoding insecticidal toxin |
| 01/30/2002 | EP0497922B1 Infective protein delivery system |
| 01/30/2002 | CN1333833A New method of identifying non-host plant disease resistance genes |
| 01/30/2002 | CN1333832A Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/30/2002 | CN1333831A Polymorphic loci that differentiate escherichia coli 0157:H7 from other strains |
| 01/30/2002 | CN1333830A Compositions and methods for therapy and diagnosis of ovarian cancer |
| 01/30/2002 | CN1333828A Compositions and methods for increasing bone mineralization |
| 01/30/2002 | CN1333820A Recombinant methods and materials for producing epothilone and eopthilone derivatives |
| 01/30/2002 | CN1333819A Method for high level expression of active lymphotoxin-betareceptor immunoglobulin |
| 01/30/2002 | CN1333818A Bioengineered tissue constructs and method for producing and using them |
| 01/30/2002 | CN1333785A Interferon-beta fusion proteins and uses |
| 01/30/2002 | CN1333691A Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells |
| 01/30/2002 | CN1333689A Method for killing tumor and tumor associated endothelial cells using adenoviral mutants |
| 01/30/2002 | CN1333688A Method and compositions for improving allogeneic hematopoietic cell transplantation |
| 01/30/2002 | CN1333339A Polytype gene of MXA protein and application thereof |
| 01/30/2002 | CN1333337A Batch production for age synchronization cell |
| 01/29/2002 | US6342596 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress |
| 01/29/2002 | US6342594 Determination of metastatic potential of cancer cells in test samples |
| 01/29/2002 | US6342584 Antiproliferative, anticarcinogenic, antitumor, antiinflammatory, and antimetastasis agents; diabetes, restenosis, rheumatoid arthritis treatment; genetic engineering |
| 01/29/2002 | US6342581 Genetic engineering and expression of polynucleotides and polypeptides; vectors, cells, antibodies for diagnosis and disease treatment |
| 01/29/2002 | US6342390 Integration of dna into chromosome of cell; does not generate virus particles; genetic expression and engineering |
| 01/29/2002 | US6342383 Reverse transcriptase activity; endogenous retroviruses |
| 01/29/2002 | US6342379 Detection of transmembrane potentials by optical methods |
| 01/29/2002 | US6342372 Culture to form protein using nutrients, isolation, culture of cells for expression of recombitant protein |
| 01/29/2002 | US6342363 Death domain containing receptor 4 nucleic acids and methods |
| 01/29/2002 | US6342351 Methods and compositions for diagnosing and treating chromosome-18p related disorders |
| 01/29/2002 | US6342344 Antibody composition for isolating human cells from human-murine chimeric hematopoietic cell suspensions |
| 01/29/2002 | US6342224 For prophylaxis and therapy of human papilloma induced tumours |
| 01/29/2002 | US6342222 Equine arteritis virus peptides, antibodies and their use in a diagnostic test |
| 01/29/2002 | US6342221 Antibody conjugate compositions for selectively inhibiting VEGF |
| 01/29/2002 | US6342220 Agonist antibodies |
| 01/29/2002 | US6342219 As anti-angiogenic and in tumor therapy |
| 01/29/2002 | US6342216 Therapy of cancer by insect cells containing recombinant baculovirus encoding genes |
| 01/29/2002 | CA2158575C Chlamydia vaccine and process |
| 01/29/2002 | CA2155330C Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 01/29/2002 | CA2075937C Anti-human plasmin-.alpha.2- plasmin inhibitor complex antibodies, hybridomas, and immunological determination method |
| 01/28/2002 | CA2353115A1 Hvd1 gene induced by salt stress |
| 01/24/2002 | WO2002006532A1 Novel dna polymerase iii holoenzyme delta subunit nucleic acid molecules and proteins |
| 01/24/2002 | WO2002006529A2 Detection and treatment of polycystic kidney disease |
| 01/24/2002 | WO2002006502A2 Adenovirus vectors comprising introns |
| 01/24/2002 | WO2002006492A1 A novel human soluble secreted endopeptidase (sep) for the treatment of sexual dysunfction |
| 01/24/2002 | WO2002006490A1 Lipoxygenase genes, promoters, transit peptides and proteins thereof |
| 01/24/2002 | WO2002006482A1 Receptor protein specifically recognizing bacterial dna |
| 01/24/2002 | WO2002006478A2 Extracellular matrix protein |
| 01/24/2002 | WO2002006463A2 Regulation of gene expression using single-chain, monomeric, ligand dependent polypeptide switches |
| 01/24/2002 | WO2002006462A2 Methylated nucleotide regulation of upa gene expression |
| 01/24/2002 | WO2002006453A2 Regulation of human desc1-like serine protease |
| 01/24/2002 | WO2002006452A2 Cloning, sequencing and expression of a comamonas cyclopentanone 1,2-monooxygenase-encoding gene in escherichia coli |
| 01/24/2002 | WO2002006450A1 Pre-adipose cell lines |
| 01/24/2002 | WO2002006340A2 Tetraspan protein and uses thereof |
| 01/24/2002 | WO2002006328A2 Type 2 dendritic cell precursor derived coding nucleic acids and related compositions and methods |
| 01/24/2002 | WO2002006324A2 Antifungal and/or antibacterial peptides, preparation methods and composition containing same |
| 01/24/2002 | WO2002006317A2 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 01/24/2002 | WO2002006311A2 Olfactory g-protein coupled receptor |
| 01/24/2002 | WO2002006308A2 Methods for promoting dendritic cell proliferation or differentiation |
| 01/24/2002 | WO2002006306A2 SUBSTRATES AND ASSAYS FOR β-SECRETASE ACTIVITY |
| 01/24/2002 | WO2002005857A2 Phosphatonin-related gene and methods of use thereof |
| 01/24/2002 | WO2002005843A2 Human rrp sequences and methods of use |
| 01/24/2002 | WO2002005811A1 Stem cell reinforcing material |
| 01/24/2002 | WO2001082780A3 Method for treating cancer, visualizing cell structures, and isolating organelles using organelle crystallizing agents |
| 01/24/2002 | WO2001079851A8 NON-INVASIVE PRENATAL DIAGNOSIS USING CD45-ve FETAL CELLS |
| 01/24/2002 | WO2001078761A3 Mixture of defibrotide and g-csf ant its use for activating haematopoietic progenitors |
| 01/24/2002 | WO2001076360A3 Synchronization of the cytoplasmatic and the nuclear maturation of oocytes in vitro |
| 01/24/2002 | WO2001070767A3 Therapeutic anti-melanoma compounds |
| 01/24/2002 | WO2001064750A3 Modulation of the activity of the endothelial cel surface receptor ecrtp/dep-1 in the regulation of angiogenesis |
| 01/24/2002 | WO2001060838A3 Aids ancestral viruses and vaccines |
| 01/24/2002 | WO2001059115A3 83p5g4: a tissue specific protein highly expressed in prostate cancer |
| 01/24/2002 | WO2001059073A3 Cytotoxic t lymphocytes activated by dendritic cell hybrids |
| 01/24/2002 | WO2001055212A3 Delivery of therapeutic biological from implantable tissue matrices |
| 01/24/2002 | WO2001051515A3 Genes differentially expressed in breast cancer |
| 01/24/2002 | WO2001046258A3 Transporters and ion channels |
| 01/24/2002 | WO2001044459A3 Method to enhance agrobacterium-mediated transformation of plants |
| 01/24/2002 | WO2001044286A3 Five-helix protein |
| 01/24/2002 | WO2001042757A3 Sperm quality assay |
| 01/24/2002 | WO2001042465A3 Chordin-like molecules and uses thereof |
| 01/24/2002 | WO2001036595A3 Methods for conditional transgene expression and trait removal in plants |
| 01/24/2002 | WO2001034768A3 15 human secreted proteins |
| 01/24/2002 | WO2001032910A3 27 human secreted proteins |
| 01/24/2002 | WO2001025436A3 Endozepine-like polypeptides and polynucleotides encoding same |
| 01/24/2002 | WO2001023409A8 38 human secreted proteins |
| 01/24/2002 | WO2001019860A3 Proteins associated with cell differentiation |
| 01/24/2002 | WO2001019855A3 Pharmaceutical compositions and methods of using secreted frizzled related protein |
| 01/24/2002 | WO2001016290A3 Dna encoding the human serine protease eos |
| 01/24/2002 | WO2001014417A3 Pesticidal proteins |
| 01/24/2002 | WO2001012819A3 Protein phosphatases and diagnosis and treatment of phosphatase-related disorders |
| 01/24/2002 | WO2000073453A9 T-bet compositions and methods of use thereof |
| 01/24/2002 | WO2000073338A9 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer |
| 01/24/2002 | US20020010952 Nucleotide sequences coding plant protein; for use in hop culturing |
| 01/24/2002 | US20020010949 Cloning using donor nuclei from differentiated fetal and adult cells |
| 01/24/2002 | US20020010948 Swine defective for transmission of porcine endogenous retrovirus and uses thereof |
| 01/24/2002 | US20020010328 Genetic engineering |
| 01/24/2002 | US20020010325 Complexing; purified polypeptide |
| 01/24/2002 | US20020010324 Genetic engineering; polypeptides |
| 01/24/2002 | US20020010318 Enzyme inhibitor; for use in treatment of lung defects, asthma, bronchitis, emphysema and respiratory system disorders |
| 01/24/2002 | US20020009807 Support for adherring cells over preferential layouts; for use in patterning biopolymer layers |
| 01/24/2002 | US20020009806 Apparatus for propagation of preferential cells and detection of cell propagation modulators |
| 01/24/2002 | US20020009805 Support for the propagation of preferential tissues |
| 01/24/2002 | US20020009803 Propagation of embryos or oocytes; obtain sample, immerse in nutrients, monitor development of samples |
| 01/24/2002 | US20020009790 Process for stabilizing proteins in an acidic environment with a pectin high-ester |